CEO of MEM just re-posted that article from TechInvest Mag via his LinkedIn account (article link: https://blog.techinvest.online/news/memphasys-advances-global-reach-with-felix-system-testing-at-jinxin-fertility-group-facility ).
Interestingly, the Chief Medical Officer of Heranova Lifesciences (the China based biotech company which MEM is now collaborating with) responded with a comment and a positive endorsement of the new collaboration between MEM and Heranova.
Images of the interaction posted below.
Exciting times ahead for MEM.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.917M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 9148745 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 2183756 | 5 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable